Stock research
PRCT PROCEPT BioRobotics Corporation
Healthcare • Medical - Devices
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated,...…
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
1Y change
-62.73%
Range high
$49.96
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in PRCT?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $18.00
- Day High
- $18.66
- Day Low
- $17.71
- 52w High
- $51.18
- 52w Low
- $16.67
- Volume
- 1,179,116
- Avg Volume
- Beta
- 0.869
* TTM/most recent where available
Company
- Ticker
- PRCT
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
- CEO
- Larry L. Wood
- Employees
- 888
- Website
- www.procept-biorobotics.com
Key Metrics
- Market Cap
- 1.06B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).